Lisa M. Meckley

989 total citations
33 papers, 730 citations indexed

About

Lisa M. Meckley is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Immunology. According to data from OpenAlex, Lisa M. Meckley has authored 33 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Immunology. Recurrent topics in Lisa M. Meckley's work include Immunodeficiency and Autoimmune Disorders (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Lisa M. Meckley is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Lisa M. Meckley collaborates with scholars based in United States, France and Switzerland. Lisa M. Meckley's co-authors include Peter J. Neumann, David L. Veenstra, Brian R. Matlaga, Jeroen P. Jansen, James E. Lingeman, James D. Chambers, Françoise Simon, Jeffrey L. Anderson, Marc S. Williams and Ann K. Wittkowsky and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Lisa M. Meckley

31 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa M. Meckley United States 14 217 198 187 183 110 33 730
C McLeod United Kingdom 16 178 0.8× 95 0.5× 99 0.5× 63 0.3× 39 0.4× 27 835
Charnita Zeigler‐Johnson United States 18 607 2.8× 43 0.2× 109 0.6× 70 0.4× 69 0.6× 62 1.4k
Christopher Sanders United States 11 44 0.2× 51 0.3× 228 1.2× 151 0.8× 50 0.5× 18 833
Elvira D’Andrea United States 22 79 0.4× 212 1.1× 33 0.2× 77 0.4× 159 1.4× 62 1.1k
Hua Lu China 14 95 0.4× 39 0.2× 65 0.3× 55 0.3× 30 0.3× 61 705
Jeremy Puthumana United States 14 132 0.6× 126 0.6× 35 0.2× 45 0.2× 74 0.7× 17 893
Mona Aeysha Khalid United Kingdom 13 428 2.0× 66 0.3× 216 1.2× 134 0.7× 127 1.2× 28 1.0k
James Chan United States 18 87 0.4× 141 0.7× 37 0.2× 44 0.2× 26 0.2× 29 947
Trine Lembrecht Jørgensen Denmark 12 156 0.7× 89 0.4× 16 0.1× 42 0.2× 99 0.9× 41 764
Carmen Fernández‐Capitán Spain 17 114 0.5× 29 0.1× 75 0.4× 32 0.2× 102 0.9× 47 749

Countries citing papers authored by Lisa M. Meckley

Since Specialization
Citations

This map shows the geographic impact of Lisa M. Meckley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Meckley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Meckley more than expected).

Fields of papers citing papers by Lisa M. Meckley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa M. Meckley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Meckley. The network helps show where Lisa M. Meckley may publish in the future.

Co-authorship network of co-authors of Lisa M. Meckley

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa M. Meckley. A scholar is included among the top collaborators of Lisa M. Meckley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa M. Meckley. Lisa M. Meckley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Howard, Kellee, Daniel C. Adelman, Sarah Acaster, et al.. (2024). Development of the celiac disease symptom diary version 2.1© (CDSD 2.1©) patient-reported outcome measure. Quality of Life Research. 33(12). 3275–3282. 1 indexed citations
2.
Meckley, Lisa M., et al.. (2023). Tu1377 THE VIRTUAL CELIAC SYMPTOMS STUDY: SYMPTOM AND GLUTEN-FREE DIET PERCEPTIONS AT BASELINE. Gastroenterology. 164(6). S–1037. 2 indexed citations
3.
Martin, Sophie, et al.. (2022). POSA362 Symptom Assessment in Adolescents and Adults with Celiac Disease. Value in Health. 25(1). S220–S220.
4.
Meckley, Lisa M., et al.. (2021). Infusion parameters of 20% subcutaneous immunoglobulin for primary immunodeficiency diseases among patient support program participants. Annals of Allergy Asthma & Immunology. 127(5). 568–574.e1. 7 indexed citations
5.
Chen, Kristina, et al.. (2020). S1301 Disease Burden and Quality of Life Impacts in Patients With Celiac Disease on a Gluten-Free Diet: An Analysis of the ICureCeliac Registry. The American Journal of Gastroenterology. 115(1). S653–S654. 1 indexed citations
6.
7.
Meckley, Lisa M., et al.. (2020). Infusion Parameters of Patients Initiated on Ig20Gly in a Patient Program by Infusion Schedule. Journal of Allergy and Clinical Immunology. 145(2). AB216–AB216. 1 indexed citations
8.
Pollock, Richard F. & Lisa M. Meckley. (2017). An Evaluation Of The Budget Impact Of The New 20% Subcutaneous Immunoglobulin (IG20GLY) For The Management Of Primary Immunodeficiency Diseases In Switzerland. Value in Health. 20(9). A549–A549. 1 indexed citations
9.
Martínez‐López, Joaquín, Tanya G. K. Bentley, Michael J. Cangelosi, et al.. (2016). Cost Effectiveness of Metal Stents in Relieving Obstructive Jaundice in Patients with Pancreatic Cancer. Journal of Gastrointestinal Cancer. 48(1). 58–65. 16 indexed citations
10.
Lim, Sangtaeck, et al.. (2015). Reduction in hospital costs and resource consumption associated with the use of advanced topical hemostats during inpatient procedures. Journal of Medical Economics. 18(6). 474–481. 12 indexed citations
11.
Miyasato, Gavin, et al.. (2015). Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats. ClinicoEconomics and Outcomes Research. 7. 567–567. 13 indexed citations
12.
Meckley, Lisa M., et al.. (2015). An observational study of glycemic control in canagliflozin treated patients. Current Medical Research and Opinion. 31(8). 1479–1486. 13 indexed citations
13.
Meckley, Lisa M., et al.. (2014). Medicare hepatitis C patients – are patients under 65 different?. Value in Health. 17(3). A36–A36. 1 indexed citations
14.
Cangelosi, Michael J., et al.. (2014). Cost–effectiveness of bronchial thermoplasty in commercially-insured patients with poorly controlled, severe, persistent asthma. Expert Review of Pharmacoeconomics & Outcomes Research. 15(2). 357–364. 24 indexed citations
15.
Matlaga, Brian R., et al.. (2013). Management Patterns of Medicare Patients Undergoing Treatment for Upper Urinary Tract Calculi. Journal of Endourology. 28(6). 723–728. 12 indexed citations
16.
Giovanni, Monica A., Lisa Soleymani Lehmann, Robert C. Green, et al.. (2010). Health-Care Referrals from Direct-to-Consumer Genetic Testing. Genetic Testing and Molecular Biomarkers. 14(6). 817–819. 47 indexed citations
17.
Meckley, Lisa M. & Peter J. Neumann. (2009). Personalized medicine: Factors influencing reimbursement. Health Policy. 94(2). 91–100. 89 indexed citations
18.
Meckley, Lisa M., et al.. (2009). A Policy Model to Evaluate the Benefits, Risks and Costs of Warfarin Pharmacogenomic Testing. PharmacoEconomics. 28(1). 61–74. 75 indexed citations
19.
Garrison, Louis P., et al.. (2008). A Review of Public Policy Issues in Promoting the Development and Commercialization of Pharmacogenomic Applications: Challenges and Implications. Drug Metabolism Reviews. 40(2). 377–401. 22 indexed citations
20.
Meckley, Lisa M. & David L. Veenstra. (2006). Screening for the alpha-adducin Gly460Trp variant in hypertensive patients: a cost-effectiveness analysis. Pharmacogenetics and Genomics. 16(2). 139–147. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C McLeod Breakdown of academic impact, for papers by Charnita Zeigler‐Johnson Breakdown of academic impact, for papers by Christopher Sanders Breakdown of academic impact, for papers by Elvira D’Andrea Breakdown of academic impact, for papers by Hua Lu Breakdown of academic impact, for papers by Jeremy Puthumana Breakdown of academic impact, for papers by Mona Aeysha Khalid Breakdown of academic impact, for papers by James Chan Breakdown of academic impact, for papers by Trine Lembrecht Jørgensen Breakdown of academic impact, for papers by Carmen Fernández‐Capitán
Rankless by CCL
2026